Liberty Health Sciences Opens Three New Medical Cannabis Education Centers In Palm Harbor, Winter Haven and Merritt Island
Liberty opens three new dispensaries in October, bringing total number of Florida locations to seven
TORONTO, Oct. 24, 2018 /CNW/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) www.libertyhealthsciences.com ("Liberty" or the "Company"), a provider of high quality cannabis, announced today the planned opening this week of three of its newest Cannabis Education Center (CEC) dispensaries in Winter Haven, FL; Palm Harbor, FL, and Merritt Island, FL featuring free 24-hour delivery service throughout Florida. Opening for the Palm Harbor and Merritt Island locations are subject to DOH approval.
The new dispensaries are located at 31486 US Highway 19 North, Palm Harbor, FL; 1285 1st Street, Winter Haven, FL, and 150 East Merritt Island Causeway, Merritt Island, FL. The dispensaries are open Monday through Friday, 10 a.m. to 7p.m., Saturday, 10 a.m. to 5 p.m., and Sunday 12 p.m. to 5 p.m. Currently, Liberty operates four dispensaries and six delivery hubs with 24-hour delivery to any resident in the state.
Liberty's CEC's offer pharmaceutical-grade cannabis products and a comprehensive platform that includes educational tools and compassionate one-on-one consultations geared towards informing customers on medical cannabis use. The Company offers a wide array of brands such as Aphria, Solei, Mary's Medicinals, Pax Era Pod devices, and Incredibles. These products aim to provide customers with a variety of high-quality options to meet their needs across all state-approved methods of cannabis consumption, including vapes, oils, tinctures and capsules.
"With these new locations, we are excited to be able to make our premium cannabis products even more accessible to more customers throughout the state of Florida," said George Scorsis, CEO of Liberty Health Sciences. "We are laser focused on creating the best operation for future growth and our strategy of being the best provider in one of the largest states in the U.S. Every day in our stores people are thrilled to be able to get access to quality products and feel welcomed in our dispensaries. We have a consistent goal to be the best provider of cannabis in the U.S. through our relentless pursuit of providing the best customer experience and we are there to help guide them on their cannabis journey."
About Liberty Health Sciences Inc.
Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale and beyond. Liberty's measured approach to expansion opportunities maximizes returns to shareholders, while keeping consumers' well-being at the forefront of what we do. For more information, please visit: www.libertyhealthsciences.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: This press release contains certain forward-looking statements within the meaning of applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as "may", "should", "anticipate", "expect", "believe", "plan", "intend" or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to, expectations related to the Company's production capabilities, expectations concerning the receipt of all necessary approvals from the Florida Department of Health, expectations concerning the opening of new dispensaries, and the Company's future expansion and growth strategies. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments involving medical marijuana; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favorable terms; the medical marijuana industry in the United States generally, income tax and regulatory matters; the ability of Liberty to implement its business strategies; competition; crop failure; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
SOURCE Liberty Health Sciences Inc.
Media Contacts: Dwain Schenck, 203-223-5230, [email protected]; Stephanie Kubacki, Vice-President, Marketing, 415-830-7337, [email protected]
Share this article